Spruce Biosciences director Dina Chaya resigns; Percival Barretto-Ko appointed to board

SPRUCE BIOSCIENCES, INC.

Dina Chaya, Ph.D., C.F.A. resigns from board and committees effective May 25, 2023; not due to any dispute.
Daniel Spiegelman appointed to Nominating Committee; Kirk Ways, M.D., Ph.D. named Chair of Nominating Committee.
Percival Barretto-Ko appointed as Class II director (term to 2025 annual meeting) and to Audit Committee.
Barretto-Ko receives option to purchase 60,000 shares vesting over 3 years, plus annual retainers of $40,000 (director) and $7,500 (audit).

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Dina Chaya

Director

SPRB · SPRUCE BIOSCIENCES, INC.

Effective: 2023-05-25
Successor: Percival Barretto-Ko
Filed: May 25, 2023, 7:59 PM ET

On May 22, 2023, Dina Chaya, Ph.D., C.F.A., notified the board of directors (the “Board”) of Spruce Biosciences, Inc. (the “Company”) of her resignation as a director of the Company and as a member of the Nominating and Corporate Governance Committee of the Board (the “Nominating Committee”) and the Audit Committee of the Board (the “Audit Committee”), effective as of May 25, 2023 (the “Effective Date”).

Appointed

Percival Barretto-Ko

Class II Director

SPRB · SPRUCE BIOSCIENCES, INC.

Effective: 2023-05-25
Filed: May 25, 2023, 7:59 PM ET

On May 23, 2023, the Board appointed Percival Barretto-Ko to the Board, to fill the vacancy resulting from Dr. Chaya's resignation, contingent upon Dr. Chaya's resignation and effective as of the Effective Date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dina Chaya resigned as Director at SPRUCE BIOSCIENCES, INC..

Action: resigned
Role: Director

Exact text from the filing

On May 22, 2023, Dina Chaya, Ph.D., C.F.A., notified the board of directors (the “Board”) of Spruce Biosciences, Inc. (the “Company”) of her resignation as a director of the Company and as a member of the Nominating and Corporate Governance Committee of the Board (the “Nominating Committee”) and the Audit Committee of the Board (the “Audit Committee”), effective as of May 25, 2023 (the “Effective Date”).

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Percival Barretto-Ko was appointed as Class II Director at SPRUCE BIOSCIENCES, INC..

Action: appointed
Role: Class II Director

Exact text from the filing

On May 23, 2023, the Board appointed Percival Barretto-Ko to the Board, to fill the vacancy resulting from Dr. Chaya's resignation, contingent upon Dr. Chaya's resignation and effective as of the Effective Date.

View on SEC.gov

SPRUCE BIOSCIENCES, INC. filing history →

Source: SEC EDGAR

accession 0000950170-23-024071

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.